Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
In clinical studies, it helped people lose about 14% of their weightcomparable to the injection
Modulatory effects of probiotics during pathogenic infections with emphasis on immune regulation
Understanding these risks is essential for both healthcare professionals and patients
Phase 2B results for AOD9604 do not support commercial viability (obesity indication)
Early-phase clinical trials including a Phase 2 dose-ranging study published in the New England Journal of Medicine (2023) have demonstrated significant potential for weight reduction and metabolic improvement, generating considerable scientific interest
Virtanen H., Soares R.N., Shearer J
US$ 23.35
US$ 21.80
US$ 22.92
US$ 21.62
